Novel Pipeline for Diagnosing Acute Lymphoblastic Leukemia Sensitive to Related Biomarkers

no code implementations • 8 Jul 2023 • Amirhossein Askari-Farsangi, Ali Sharifi-Zarchi, Mohammad Hossein Rohban

We introduced a novel pipeline for diagnosing ALL that approximates the process used by hematologists, is sensitive to disease biomarkers, and achieves an accuracy of 96. 15%, an F1-score of 94. 24%, a sensitivity of 97. 56%, and a specificity of 90. 91% on ALL IDB 1.

Multiple Instance Learning Specificity